FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Suzanne Topalian

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Procedures

Immunotherapy

Concepts & Ideas

Co-author Network

Publications

TOP 3
Sofia Lyford-Pike; Belinda Akpeng; Justin A Bishop; Tullia C Bruno; Lieping Chen; Charles G Drake; Drew M Pardoll; Shiwen Peng; Jeremy D Richmon; Janis M Taube; Suzanne Topalian; Hao Wang; William H Westra; Geoffrey D Young; Sara I Pai
Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma.
Evan J Lipson; Drew M Pardoll; Alice Pons; WILLIAM SHARFMAN; Janis M Taube; Robert A Anders; Julie R Brahmer; Lieping Chen; Charles G Drake; Ira Wollner; Haiying Xu; Sheng Yao; Suzanne Topalian
Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibody.
Lu Deng; Ries J Langley; Suzanne Topalian; Qian Wang; Roy A Mariuzza
Structural insights into the editing of germ-line-encoded interactions between T-cell receptor and MHC class II by Vα CDR3.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Suzanne Topalian (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sofia Lyford-Pike; Belinda Akpeng; Justin A Bishop; Tullia C Bruno; Lieping Chen; Charles G Drake; Drew M Pardoll; Shiwen Peng; Jeremy D Richmon; Janis M Taube; Suzanne Topalian; Hao Wang; William H Westra; Geoffrey D Young; Sara I Pai
Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma.
Cancer research 2013;73(6):1733-41.
2013: Evan J Lipson; Drew M Pardoll; Alice Pons; WILLIAM SHARFMAN; Janis M Taube; Robert A Anders; Julie R Brahmer; Lieping Chen; Charles G Drake; Ira Wollner; Haiying Xu; Sheng Yao; Suzanne Topalian
Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibody.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(2):462-8.
2012: Lu Deng; Ries J Langley; Suzanne Topalian; Qian Wang; Roy A Mariuzza
Structural insights into the editing of germ-line-encoded interactions between T-cell receptor and MHC class II by Vα CDR3.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(37):14960-5.
2012: Julie R Brahmer; Luis H Camacho; Shuming Chen; Laura Q M Chow; Charles G Drake; Keith Eaton; Stacie M Goldberg; Joseph F Grosso; Ashok Gupta; Omid Hamid; Patrick Hwu; Wen-Jen Hwu; John Kauh; Alan J Korman; Renato Martins; Kunle Odunsi; Drew M Pardoll; Susan M Parker; Henry C Pitot; Theresa M Salay; Suzanne Topalian; Scott S Tykodi; Shruti Agrawal; Suresh Alaparthy; Shailender Bhatia; JON WIGGINTON
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.
The New England journal of medicine 2012;366(26):2455-65.
2012: Suzanne Topalian; JON WIGGINTON; Haiying Xu; Janis M Taube; Shruti Agrawal; Robert A Anders; Scott J Antonia; Michael B Atkins; Julie R Brahmer; Richard D Carvajal; Lieping Chen; Charles G Drake; Scott N Gettinger; Ashok Gupta; F Stephen Hodi; Leora Horn; Maria Jure-Kunkel; Georgia D Kollia; Alan J Korman; Philip D Leming; David F McDermott; Daniel McDonald; Tracee L McMiller; Drew M Pardoll; John D Powderly; WILLIAM SHARFMAN; David C Smith; Jeffrey A Sosman; David R Spigel; Mario Sznol
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.
The New England journal of medicine 2012;366(26):2443-54.
2012: Suzanne Topalian; Charles G Drake; Drew M Pardoll
Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity.
Current opinion in immunology 2012;24(2):207-12.
2012: Janis M Taube; Suzanne Topalian; Haiying Xu; Geoffrey D Young; Shuming Chen; Alison P Klein; Tracee L McMiller; Drew M Pardoll; Rajni Sharma; Robert A Anders; Lieping Chen
Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape.
Science translational medicine 2012;4(127):127ra37.
2012: Laurie H Glimcher; Olle Lindvall; Kiran Musunuru; Suzanne Topalian; Vince Aguirre; Anthony S Fauci
Translating research into therapies.
Cell 2012;148(6):1077-8.
2012: Ivan Martinez Forero; Thomas F Gajewski; Alan J Korman; Hideho Okada; Suzanne Topalian; Ignacio Melero
Workshop on immunotherapy combinations. Society for Immunotherapy of Cancer annual meeting Bethesda, November 3, 2011.
Journal of translational medicine 2012;10():108.
2011: Suzanne Topalian; George J Weiner; Drew M Pardoll
Cancer immunotherapy comes of age.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(36):4828-36.
2011: Eric V Dang; Juan Fu; Dilini Jinasena; Young Kim; Weibo Luo; Joseph Barbi; Zachary Bordman; Chi Dang; Drew M Pardoll; Gregg L Semenza; Larissa A Shimoda; Suzanne Topalian; Huang-Yu Yang; Hung-Rong Yen; Hong Yu; Karen I Zeller; Ying Zheng; Fan Pan
Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1.
Cell 2011;146(5):772-84.
2011: Rachel W Humphrey; Kathleen M Dohoney; James H Doroshow; Sandra J Meech; Mark J Ratain; Suzanne Topalian; David T Bonk; Laura M Brockway-Lunardi; Drew M Pardoll
Opportunities and challenges in the development of experimental drug combinations for cancer.
Journal of the National Cancer Institute 2011;103(16):1222-6.
2010: Richard E Royal; Catherine Levy; Keli Turner; Aarti Mathur; Marybeth Hughes; Udai S Kammula; Richard M Sherry; Suzanne Topalian; James C Yang; Israel Lowy; STEVEN ROSENBERG
Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2010;33(8):828-33.
2010: Julie R Brahmer; Charles G Drake; Ira Wollner; John D Powderly; Joel Picus; WILLIAM SHARFMAN; Elizabeth Stankevich; Alice Pons; Theresa M Salay; Tracee L McMiller; MARTA GILSON; Changyu Wang; Mark Selby; Janis M Taube; Robert A Anders; Lieping Chen; Alan J Korman; Drew M Pardoll; Israel Lowy; Suzanne Topalian
Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(19):3167-75.
2010: Yili Li; Florence R Depontieu; John Sidney; Theresa M Salay; Victor H Engelhard; Donald F Hunt; Alessandro Sette; Suzanne Topalian; Roy A Mariuzza
Structural basis for the presentation of tumor-associated MHC class II-restricted phosphopeptides to CD4+ T cells.
Journal of molecular biology 2010;399(4):596-603.
2009: Florence R Depontieu; Jie Qian; Angela L Zarling; Tracee L McMiller; Theresa M Salay; Andrew Norris; A Michelle English; Jeffrey Shabanowitz; Victor H Engelhard; Donald F Hunt; Suzanne Topalian
Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(29):12073-8.
2008: Suhail K Mithani; Ian M Smith; Suzanne Topalian; Joseph A Califano
Nonsynonymous somatic mitochondrial mutations occur in the majority of cutaneous melanomas.
Melanoma research 2008;18(3):214-9.
2007: James C Yang; Marybeth Hughes; Udai S Kammula; Richard E Royal; Richard M Sherry; Suzanne Topalian; Kimberly B Suri; Catherine Levy; Tamika Allen; Sharon A Mavroukakis; Israel Lowy; Donald E White; STEVEN ROSENBERG
Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitis.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2007;30(8):825-30.
2007: Lu Deng; Ries J Langley; Patrick Brown; Gang Xu; Leslie Teng; Qian Wang; Monica I Gonzales; Glenda G Callender; Michael I Nishimura; Suzanne Topalian; Roy A Mariuzza
Structural basis for the recognition of mutant self by a tumor-specific, MHC class II-restricted T cell receptor.
Nature immunology 2007;8(4):398-408.
2006: Richard A Morgan; Mark E Dudley; John R Wunderlich; Marybeth S Hughes; James C Yang; Richard M Sherry; Richard E Royal; Suzanne Topalian; Udai S Kammula; Nicholas P Restifo; Zhili Zheng; Azam Nahvi; Christiaan R de Vries; Linda Rogers-Freezer; Sharon A Mavroukakis; STEVEN ROSENBERG
Cancer regression in patients after transfer of genetically engineered lymphocytes.
Science (New York, N.Y.) 2006;314(5796):126-9.
2006: Ajay V Maker; James C Yang; Richard M Sherry; Suzanne Topalian; Udai S Kammula; Richard E Royal; Marybeth Hughes; Michael Yellin; Leah R Haworth; Catherine Levy; Tamika Allen; Sharon A Mavroukakis; Peter Attia; STEVEN ROSENBERG
Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2006;29(4):455-63.
2006: Kimberly E Beck; Joseph A Blansfield; Khoi Q Tran; Andrew L Feldman; Marybeth S Hughes; Richard E Royal; Udai S Kammula; Suzanne Topalian; Richard M Sherry; David Kleiner; Martha Quezado; Israel Lowy; Michael Yellin; STEVEN ROSENBERG; James C Yang
Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(15):2283-9.
2006: Kimberly R Lindsey; Linda Gritz; Richard M Sherry; Andrea Abati; Patricia A Fetsch; Lisa C Goldfeder; Monica I Gonzales; Kimberly A Zinnack; Linda Rogers-Freezer; Leah R Haworth; Sharon A Mavroukakis; Donald E White; Seth M Steinberg; Nicholas P Restifo; Dennis Panicali; STEVEN ROSENBERG; Suzanne Topalian
Evaluation of prime/boost regimens using recombinant poxvirus/tyrosinase vaccines for the treatment of patients with metastatic melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(8):2526-37.
2006: STEVEN ROSENBERG; Richard M Sherry; Kathleen E Morton; James C Yang; Suzanne Topalian; Richard E Royal; Udai S Kammula; Nicholas P Restifo; Marybeth S Hughes; Susan L Schwarz; Lien T Ngo; Sharon A Mavroukakis; Donald E White
Altered CD8(+) T-cell responses when immunizing with multiepitope peptide vaccines.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2006;29(2):224-31.
2005: Ajay V Maker; Giao Q Phan; Peter Attia; James C Yang; Richard M Sherry; Suzanne Topalian; Udai S Kammula; Richard E Royal; Leah R Haworth; Catherine Levy; David Kleiner; Sharon A Mavroukakis; Michael Yellin; STEVEN ROSENBERG
Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study.
Annals of surgical oncology 2005;12(12):1005-16.
2005: STEVEN ROSENBERG; Richard M Sherry; Kathleen E Morton; William J Scharfman; James C Yang; Suzanne Topalian; Richard E Royal; Udai S Kammula; Nicholas P Restifo; Marybeth S Hughes; Douglas J Schwartzentruber; berman david; Susan L Schwarz; Lien T Ngo; Sharon A Mavroukakis; Donald E White; Seth M Steinberg
Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(9):6169-76.
2005: Joseph A Blansfield; Kimberly E Beck; Khoi Tran; James C Yang; Marybeth S Hughes; Udai S Kammula; Richard E Royal; Suzanne Topalian; Leah R Haworth; Catherine Levy; STEVEN ROSENBERG; Richard M Sherry
Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2005;28(6):593-8.
2005: Peter Attia; Giao Q Phan; Ajay V Maker; Michael R Robinson; Martha Quezado; James C Yang; Richard M Sherry; Suzanne Topalian; Udai S Kammula; Richard E Royal; Nicholas P Restifo; Leah R Haworth; Catherine Levy; Sharon A Mavroukakis; Geoffrey Nichol; Michael Yellin; STEVEN ROSENBERG
Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(25):6043-53.
2005: Mark E Dudley; John R Wunderlich; James C Yang; Richard M Sherry; Suzanne Topalian; Nicholas P Restifo; Richard E Royal; Udai S Kammula; Donald E White; Sharon A Mavroukakis; Linda J Rogers; Gerald J Gracia; Stephanie A Jones; David P Mangiameli; Michelle M Pelletier; Juan Gea-Banacloche; Michael R Robinson; berman david; Armando C Filie; Andrea Abati; STEVEN ROSENBERG
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(10):2346-57.
2004: Hung T Khong; James C Yang; Suzanne Topalian; Richard M Sherry; Sharon A Mavroukakis; Donald E White; STEVEN ROSENBERG
Immunization of HLA-A*0201 and/or HLA-DPbeta1*04 patients with metastatic melanoma using epitopes from the NY-ESO-1 antigen.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2004;27(6):472-7.
2004: Gregory Lizée; Monica I Gonzales; Suzanne Topalian
Lentivirus vector-mediated expression of tumor-associated epitopes by human antigen presenting cells.
Human gene therapy 2004;15(4):393-404.
2004: Melinda S Sharkey; Gregory Lizée; Monica I Gonzales; Sima Patel; Suzanne Topalian
CD4(+) T-cell recognition of mutated B-RAF in melanoma patients harboring the V599E mutation.
Cancer research 2004;64(5):1595-9.
2004: Joeri L Aerts; Monica I Gonzales; Suzanne Topalian
Selection of appropriate control genes to assess expression of tumor antigens using real-time RT-PCR.
BioTechniques 2004;36(1):84-6, 88, 90-1.
2003: STEVEN ROSENBERG; James C Yang; Paul F Robbins; John R Wunderlich; Patrick Hwu; Richard M Sherry; Douglas J Schwartzentruber; Suzanne Topalian; Nicholas P Restifo; Armando C Filie; Richard Chang; Mark E Dudley
Cell transfer therapy for cancer: lessons from sequential treatments of a patient with metastatic melanoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2003;26(5):385-93.
2003: James C Yang; Richard M Sherry; Seth M Steinberg; Suzanne Topalian; Douglas J Schwartzentruber; Patrick Hwu; Claudia A Seipp; Linda Rogers-Freezer; Kathleen E Morton; Donald E White; David J Liewehr; Maria J Merino; STEVEN ROSENBERG
Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(16):3127-32.
2003: STEVEN ROSENBERG; James C Yang; Douglas J Schwartzentruber; Patrick Hwu; Suzanne Topalian; Richard M Sherry; Nicholas P Restifo; John R Wunderlich; Claudia A Seipp; Linda Rogers-Freezer; Kathleen E Morton; Sharon A Mavroukakis; Linda Gritz; Dennis Panicali; Donald E White
Recombinant fowlpox viruses encoding the anchor-modified gp100 melanoma antigen can generate antitumor immune responses in patients with metastatic melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(8):2973-80.
2003: James C Yang; Leah R Haworth; Richard M Sherry; Patrick Hwu; Douglas J Schwartzentruber; Suzanne Topalian; Seth M Steinberg; Helen X Chen; STEVEN ROSENBERG
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer.
The New England journal of medicine 2003;349(5):427-34.
2003: Giao Q Phan; James C Yang; Richard M Sherry; Patrick Hwu; Suzanne Topalian; Douglas J Schwartzentruber; Nicholas P Restifo; Leah R Haworth; Claudia A Seipp; Linda J Freezer; Kathleen E Morton; Sharon A Mavroukakis; Paul H Duray; Seth M Steinberg; James P Allison; Thomas A Davis; STEVEN ROSENBERG
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(14):8372-7.
2003: Giao Q Phan; Christopher E Touloukian; James C Yang; Nicholas P Restifo; Richard M Sherry; Patrick Hwu; Suzanne Topalian; Douglas J Schwartzentruber; Claudia A Seipp; Linda J Freezer; Kathleen E Morton; Sharon A Mavroukakis; Donald E White; STEVEN ROSENBERG
Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigens.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2003;26(4):349-56.
2003: STEVEN ROSENBERG; James C Yang; Richard M Sherry; Patrick Hwu; Suzanne Topalian; Douglas J Schwartzentruber; Nicholas P Restifo; Leah R Haworth; Claudia A Seipp; Linda J Freezer; Kathleen E Morton; Sharon A Mavroukakis; Donald E White
Inability to immunize patients with metastatic melanoma using plasmid DNA encoding the gp100 melanoma-melanocyte antigen.
Human gene therapy 2003;14(8):709-14.
2003: Gregory Lizée; Joeri L Aerts; Monica I Gonzales; Nachimuthu Chinnasamy; Richard A Morgan; Suzanne Topalian
Real-time quantitative reverse transcriptase-polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expression.
Human gene therapy 2003;14(6):497-507.
2002: Mark E Dudley; John R Wunderlich; Paul F Robbins; James C Yang; Patrick Hwu; Douglas J Schwartzentruber; Suzanne Topalian; Richard M Sherry; Nicholas P Restifo; Amy M Hubicki; Michael R Robinson; Mark Raffeld; Paul H Duray; Claudia A Seipp; Linda Rogers-Freezer; Kathleen E Morton; Sharon A Mavroukakis; Donald E White; STEVEN ROSENBERG
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes.
Science (New York, N.Y.) 2002;298(5594):850-4.
2002: Suzanne Topalian; Monica I Gonzales; Yvona Ward; Xiang Wang; Rongfu Wang
Revelation of a cryptic major histocompatibility complex class II-restricted tumor epitope in a novel RNA-processing enzyme.
Cancer research 2002;62(19):5505-9.
2002: Franck Housseau; Kimberly R Lindsey; Samuel D Oberholtzer; Monica I Gonzales; Paula Boutin; Anitha Moorthy; Srinivas Shankara; Bruce L Roberts; Suzanne Topalian
Quantitative real-time RT-PCR as a method for monitoring T lymphocyte reactivity to full-length tyrosinase protein in vaccinated melanoma patients.
Journal of immunological methods 2002;266(1-2):87-103.
2002: Mark E Dudley; John R Wunderlich; James C Yang; Patrick Hwu; Douglas J Schwartzentruber; Suzanne Topalian; Richard M Sherry; Francesco M Marincola; Susan F Leitman; Claudia A Seipp; Linda Rogers-Freezer; Kathleen E Morton; Azam Nahvi; Sharon A Mavroukakis; Donald E White; STEVEN ROSENBERG
A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2002;25(3):243-51.
2002: Franck Housseau; Daniel A Langer; Samuel D Oberholtzer; Anitha Moorthy; Hyam I Levitsky; Drew M Pardoll; Suzanne Topalian
Tumor-specific CD8+ T lymphocytes derived from the peripheral blood of prostate cancer patients by in vitro stimulation with autologous tumor cell lines.
International journal of cancer. Journal international du cancer 2002;98(1):57-62.
2002: John F Toso; Vee J Gill; Patrick Hwu; Francesco M Marincola; Nicholas P Restifo; Douglas J Schwartzentruber; Richard M Sherry; Suzanne Topalian; James C Yang; Frida Stock; Linda J Freezer; Kathleen E Morton; Claudia A Seipp; Leah R Haworth; Sharon A Mavroukakis; Donald White; Susan MacDonald; John Mao; Mario Sznol; STEVEN ROSENBERG
Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(1):142-52.
2001: Franck Housseau; Anitha Moorthy; D A Langer; Paul F Robbins; Monica I Gonzales; Suzanne Topalian
N-linked carbohydrates in tyrosinase are required for its recognition by human MHC class II-restricted CD4(+) T cells.
European journal of immunology 2001;31(9):2690-701.
2001: Suzanne Topalian; Syuzo Kaneko; Monica I Gonzales; Gareth Bond; Yvona Ward; J L Manley
Identification and functional characterization of neo-poly(A) polymerase, an RNA processing enzyme overexpressed in human tumors.
Molecular and cellular biology 2001;21(16):5614-23.
2001: Mark E Dudley; John R Wunderlich; Michael I Nishimura; D Yu; James C Yang; Suzanne Topalian; Douglas J Schwartzentruber; Patrick Hwu; Francesco M Marincola; Richard M Sherry; Susan F Leitman; STEVEN ROSENBERG
Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2001;24(4):363-73.
2001: Richard M Simon; Seth M Steinberg; M Hamilton; A Hildesheim; Samir N Khleif; L W Kwak; CRYSTAL MACKALL; Jeffrey Schlom; Suzanne Topalian; Jay A Berzofsky
Clinical trial designs for the early clinical development of therapeutic cancer vaccines.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(6):1848-54.
2000: David K Ornstein; John W Gillespie; Cloud P Paweletz; Paul H Duray; Judi C Herring; Cathy D Vocke; Suzanne Topalian; David G Bostwick; W Marston Linehan; Emanuel F Petricoin; Michael R Emmert-Buck
Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines.
Electrophoresis 2000;21(11):2235-42.
2000: Christopher E Touloukian; Wolfgang W Leitner; Suzanne Topalian; Yong F Li; Paul F Robbins; STEVEN ROSENBERG; Nicholas P Restifo
Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(7):3535-42.
1999: Franck Housseau; Robert K Bright; T Simonis; Michael I Nishimura; Suzanne Topalian
Recognition of a shared human prostate cancer-associated antigen by nonclassical MHC-restricted CD8+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(11):6330-7.
1999: STEVEN ROSENBERG; James C Yang; Douglas J Schwartzentruber; Patrick Hwu; Francesco M Marincola; Suzanne Topalian; Nicholas P Restifo; Mario Sznol; Susan L Schwarz; Paul J Spiess; John R Wunderlich; Claudia A Seipp; JH Einhorn; Linda Rogers-Freezer; Donald E White
Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccine.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(3):1690-5.
1999: Rongfu Wang; X Wang; A C Atwood; Suzanne Topalian; STEVEN ROSENBERG
Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen.
Science (New York, N.Y.) 1999;284(5418):1351-4.
1999: STEVEN ROSENBERG; James C Yang; Douglas J Schwartzentruber; Patrick Hwu; Francesco M Marincola; Suzanne Topalian; Claudia A Seipp; JH Einhorn; Donald E White; Seth M Steinberg
Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):968-75.
1999: Rembert Pieper; Robert E Christian; Monica I Gonzales; Michael I Nishimura; Ghanshyam Gupta; Robert E Settlage; Jeffrey Shabanowitz; STEVEN ROSENBERG; Donald F Hunt; Suzanne Topalian
Biochemical identification of a mutated human melanoma antigen recognized by CD4(+) T cells.
The Journal of experimental medicine 1999;189(5):757-66.
1998: STEVEN ROSENBERG; Y Zhai; James C Yang; Douglas J Schwartzentruber; Patrick Hwu; Francesco M Marincola; Suzanne Topalian; Nicholas P Restifo; Claudia A Seipp; JH Einhorn; B Roberts; Donald E White
Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens.
Journal of the National Cancer Institute 1998;90(24):1894-900.
1998: Drew M Pardoll; Suzanne Topalian
The role of CD4+ T cell responses in antitumor immunity.
Current opinion in immunology 1998;10(5):588-94.
1998: Rongfu Wang; S L Johnston; Gang Zeng; Suzanne Topalian; Douglas J Schwartzentruber; STEVEN ROSENBERG
A breast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(7):3598-606.
1998: STEVEN ROSENBERG; James C Yang; Douglas J Schwartzentruber; Patrick Hwu; Francesco M Marincola; Suzanne Topalian; Nicholas P Restifo; Mark E Dudley; Susan L Schwarz; Paul J Spiess; John R Wunderlich; Maria R Parkhurst; Y Kawakami; Claudia A Seipp; JH Einhorn; Donald E White
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma.
Nature medicine 1998;4(3):321-7.
1998: JN Cormier; Andrea Abati; Patricia A Fetsch; Yasmine Hijazi; STEVEN ROSENBERG; Francesco M Marincola; Suzanne Topalian
Comparative analysis of the in vivo expression of tyrosinase, MART-1/Melan-A, and gp100 in metastatic melanoma lesions: implications for immunotherapy.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1998;21(1):27-31.
1998: James C Yang; Alfred E Chang; A R Baker; W F Sindelar; D N Danforth; Suzanne Topalian; T DeLaney; E Glatstein; S M Steinberg; M J Merino; STEVEN ROSENBERG
Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):197-203.
1997: R K Bright; Cathy D Vocke; Michael R Emmert-Buck; Paul H Duray; D Solomon; Patricia A Fetsch; Johng S Rhim; W Marston Linehan; Suzanne Topalian
Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens.
Cancer research 1997;57(5):995-1002.
1996: Suzanne Topalian; M I Gonzales; Maria R Parkhurst; Y F Li; S Southwood; A Sette; STEVEN ROSENBERG; Paul F Robbins
Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes.
The Journal of experimental medicine 1996;183(5):1965-71.
1996: Richard E Royal; Seth M Steinberg; R S Krouse; G Heywood; Donald E White; Patrick Hwu; Francesco M Marincola; D R Parkinson; Douglas J Schwartzentruber; Suzanne Topalian; J C Yang; STEVEN ROSENBERG
Correlates of response to IL-2 therapy in patients treated for metastatic renal cancer and melanoma.
The cancer journal from Scientific American 1996;2(2):91-8.
1995: J C Yang; Suzanne Topalian; Douglas J Schwartzentruber; D R Parkinson; Francesco M Marincola; J S Weber; Claudia A Seipp; Donald E White; STEVEN ROSENBERG
The use of polyethylene glycol-modified interleukin-2 (PEG-IL-2) in the treatment of patients with metastatic renal cell carcinoma and melanoma. A phase I study and a randomized prospective study comparing IL-2 alone versus IL-2 combined with PEG-IL-2.
Cancer 1995;76(4):687-94.
1995: N R Markus; STEVEN ROSENBERG; Suzanne Topalian
Analysis of cytokine secretion by melanoma-specific CD4+ T lymphocytes.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1995;15(8):739-46.
1995: Licia Rivoltini; K C Barracchini; V Viggiano; Y Kawakami; A Smith; Arnold Mixon; Nicholas P Restifo; Suzanne Topalian; TB Simonis; STEVEN ROSENBERG
Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes.
Cancer research 1995;55(14):3149-57.
1995: Paul F Robbins; Mona El-Gamil; Y F Li; Suzanne Topalian; Licia Rivoltini; Kazuyasu Sakaguchi; Ettore Appella; Y Kawakami; STEVEN ROSENBERG
Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(11):5944-50.
1994: A S Guleria; J C Yang; Suzanne Topalian; J S Weber; D R Parkinson; M P MacFarlane; R L White; Seth M Steinberg; Donald E White; JH Einhorn
Renal dysfunction associated with the administration of high-dose interleukin-2 in 199 consecutive patients with metastatic melanoma or renal carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(12):2714-22.
1994: David J Cole; D P Weil; Peter Shamamian; Licia Rivoltini; Y Kawakami; Suzanne Topalian; C Jennings; S Eliyahu; STEVEN ROSENBERG; Michael I Nishimura
Identification of MART-1-specific T-cell receptors: T cells utilizing distinct T-cell receptor variable and joining regions recognize the same tumor epitope.
Cancer research 1994;54(20):5265-8.
1994: Suzanne Topalian
MHC class II restricted tumor antigens and the role of CD4+ T cells in cancer immunotherapy.
Current opinion in immunology 1994;6(5):741-5.
1994: Suzanne Topalian; Licia Rivoltini; M Mancini; N R Markus; Paul F Robbins; Y Kawakami; STEVEN ROSENBERG
Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(20):9461-5.
1994: STEVEN ROSENBERG; J R Yannelli; J C Yang; Suzanne Topalian; Douglas J Schwartzentruber; J S Weber; D R Parkinson; Claudia A Seipp; JH Einhorn; Donald E White
Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2.
Journal of the National Cancer Institute 1994;86(15):1159-66.
1994: J C Yang; Suzanne Topalian; D Parkinson; Douglas J Schwartzentruber; J S Weber; S E Ettinghausen; Donald E White; Seth M Steinberg; David J Cole; H I Kim
Randomized comparison of high-dose and low-dose intravenous interleukin-2 for the therapy of metastatic renal cell carcinoma: an interim report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(8):1572-6.
1994: Peter Shamamian; M Mancini; Y Kawakami; Nicholas P Restifo; STEVEN ROSENBERG; Suzanne Topalian
Recognition of neuroectodermal tumors by melanoma-specific cytotoxic T lymphocytes: evidence for antigen sharing by tumors derived from the neural crest.
Cancer immunology, immunotherapy : CII 1994;39(2):73-83.
1994: Douglas J Schwartzentruber; S S Hom; R Dadmarz; Donald E White; J R Yannelli; Seth M Steinberg; STEVEN ROSENBERG; Suzanne Topalian
In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(7):1475-83.
1994: Suzanne Topalian; Licia Rivoltini; M Mancini; J Ng; R J Hartzman; STEVEN ROSENBERG
Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells.
International journal of cancer. Journal international du cancer 1994;58(1):69-79.
1994: J Weber; H Gunn; J Yang; D Parkinson; Suzanne Topalian; Douglas J Schwartzentruber; S Ettinghausen; D Levitt; STEVEN ROSENBERG
A phase I trial of intravenous interleukin-6 in patients with advanced cancer.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1994;15(4):292-302.
1994: Y Kawakami; S Eliyahu; C H Delgado; Paul F Robbins; Licia Rivoltini; Suzanne Topalian; Toru Miki; STEVEN ROSENBERG
Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(9):3515-9.
1994: STEVEN ROSENBERG; J C Yang; Suzanne Topalian; Douglas J Schwartzentruber; J S Weber; D R Parkinson; Claudia A Seipp; JH Einhorn; Donald E White
Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2.
JAMA : the journal of the American Medical Association 1994;271(12):907-13.
1994: B A Pockaj; J C Yang; M T Lotze; Julie R Lange; W F Spencer; Seth M Steinberg; Suzanne Topalian; Douglas J Schwartzentruber; Donald E White; STEVEN ROSENBERG
A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin-2 therapy.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1994;15(1):22-8.
1993: STEVEN ROSENBERG; W French Anderson; M Blaese; Patrick Hwu; J R Yannelli; J C Yang; Suzanne Topalian; Douglas J Schwartzentruber; J S Weber; S E Ettinghausen
The development of gene therapy for the treatment of cancer.
Annals of surgery 1993;218(4):455-63; discussion 463-4.
1993: Douglas J Schwartzentruber; Maryalice Stetler-Stevenson; STEVEN ROSENBERG; Suzanne Topalian
Tumor-infiltrating lymphocytes derived from select B-cell lymphomas secrete granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha in response to autologous tumor stimulation.
Blood 1993;82(4):1204-11.
1993: Y Kawakami; Michael I Nishimura; Nicholas P Restifo; Suzanne Topalian; Bert O Neil; joel shilyansky; J R Yannelli; STEVEN ROSENBERG
T-cell recognition of human melanoma antigens.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1993;14(2):88-93.
1993: Francesco M Marincola; J Balkissoon; Douglas J Schwartzentruber; S S Hom; R Concepcion; S G Marcus; J Yannelli; Suzanne Topalian; D R Parkinson; STEVEN ROSENBERG
Hemodynamic effects of the administration of tumor-infiltrating lymphocytes to cancer patients.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1993;13(4):282-8.
1993: STEVEN ROSENBERG; M T Lotze; J C Yang; Suzanne Topalian; Alfred E Chang; Douglas J Schwartzentruber; P Aebersold; Susan F Leitman; W Marston Linehan; Claudia A Seipp
Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer.
Journal of the National Cancer Institute 1993;85(8):622-32.
1993: J Weber; J C Yang; Suzanne Topalian; D R Parkinson; D S Schwartzentruber; S E Ettinghausen; H Gunn; Arnold Mixon; H Kim; David J Cole
Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(3):499-506.
1993: S S Hom; Douglas J Schwartzentruber; STEVEN ROSENBERG; Suzanne Topalian
Specific release of cytokines by lymphocytes infiltrating human melanomas in response to shared melanoma antigens.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1993;13(1):18-30.
1993: S S Hom; STEVEN ROSENBERG; Suzanne Topalian
Specific immune recognition of autologous tumor by lymphocytes infiltrating colon carcinomas: analysis by cytokine secretion.
Cancer immunology, immunotherapy : CII 1993;36(1):1-8.
1993: B A Pockaj; Suzanne Topalian; Seth M Steinberg; Donald E White; STEVEN ROSENBERG
Infectious complications associated with interleukin-2 administration: a retrospective review of 935 treatment courses.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(1):136-47.
1993: R Zakut; Suzanne Topalian; Y Kawakami; M Mancini; S Eliyahu; STEVEN ROSENBERG
Differential expression of MAGE-1, -2, and -3 messenger RNA in transformed and normal human cell lines.
Cancer research 1993;53(1):5-8.
1992: Julie R Lange; A A Raubitschek; B A Pockaj; W F Spencer; M T Lotze; Suzanne Topalian; J C Yang; STEVEN ROSENBERG
A pilot study of the combination of interleukin-2-based immunotherapy and radiation therapy.
Journal of immunotherapy : official journal of the Society for Biological Therapy 1992;12(4):265-71.
1992: Suzanne Topalian; S S Hom; Y Kawakami; M Mancini; Douglas J Schwartzentruber; R Zakut; STEVEN ROSENBERG
Recognition of shared melanoma antigens by human tumor-infiltrating lymphocytes.
Journal of immunotherapy : official journal of the Society for Biological Therapy 1992;12(3):203-6.
1992: Martin G Sanda; J C Yang; Suzanne Topalian; E S Groves; A Childs; Rubens Belfort; MD de Smet; Douglas J Schwartzentruber; Donald E White; M T Lotze
Intravenous administration of recombinant human macrophage colony-stimulating factor to patients with metastatic cancer: a phase I study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(10):1643-9.
1992: Douglas J Schwartzentruber; D Solomon; STEVEN ROSENBERG; Suzanne Topalian
Characterization of lymphocytes infiltrating human breast cancer: specific immune reactivity detected by measuring cytokine secretion.
Journal of immunotherapy : official journal of the Society for Biological Therapy 1992;12(1):1-12.
1992: Richard B Alexander; E S Bolton; Scott Koenig; G M Jones; Suzanne Topalian; Carl H June; STEVEN ROSENBERG
Detection of antigen specific T lymphocytes by determination of intracellular calcium concentration using flow cytometry.
Journal of immunological methods 1992;148(1-2):131-41.
1992: Y Kawakami; R Zakut; Suzanne Topalian; H Stötter; STEVEN ROSENBERG
Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(2):638-43.
1992: W F Spencer; W Marston Linehan; McClellan Walther; Gabriel P Haas; M T Lotze; Suzanne Topalian; J C Yang; Maria J Merino; Julie R Lange; B A Pockaj
Immunotherapy with interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer with in situ primary cancers: a pilot study.
The Journal of urology 1992;147(1):24-30.
1992: J S Weber; J C Yang; Suzanne Topalian; Douglas J Schwartzentruber; Donald E White; STEVEN ROSENBERG
The use of interleukin-2 and lymphokine-activated killer cells for the treatment of patients with non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(1):33-40.
1991: P Aebersold; C Hyatt; S Johnson; Kenneth Hines; L Korcak; M Sanders; M Lotze; Suzanne Topalian; J Yang; STEVEN ROSENBERG
Lysis of autologous melanoma cells by tumor-infiltrating lymphocytes: association with clinical response.
Journal of the National Cancer Institute 1991;83(13):932-7.
1991: S S Hom; Suzanne Topalian; TB Simonis; M Mancini; STEVEN ROSENBERG
Common expression of melanoma tumor-associated antigens recognized by human tumor infiltrating lymphocytes: analysis by human lymphocyte antigen restriction.
Journal of immunotherapy : official journal of the Society for Biological Therapy 1991;10(3):153-64.
1991: Douglas J Schwartzentruber; Suzanne Topalian; M Mancini; STEVEN ROSENBERG
Specific release of granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-alpha, and IFN-gamma by human tumor-infiltrating lymphocytes after autologous tumor stimulation.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(10):3674-81.
1990: S Morecki; Suzanne Topalian; W W Myers; D Okrongly; T B Okarma; STEVEN ROSENBERG
Separation and growth of human CD4+ and CD8+ tumor-infiltrating lymphocytes and peripheral blood mononuclear cells by direct positive panning on covalently attached monoclonal antibody-coated flasks.
Journal of biological response modifiers 1990;9(5):463-74.
1990: STEVEN ROSENBERG; P Aebersold; Kenneth Cornetta; A Kasid; Richard A Morgan; R Moen; E M Karson; M T Lotze; J C Yang; Suzanne Topalian
Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction.
The New England journal of medicine 1990;323(9):570-8.
1990: Y Skornick; Suzanne Topalian; STEVEN ROSENBERG
Comparative studies of the long-term growth of lymphocytes from tumor infiltrates, tumor-draining lymph nodes, and peripheral blood by repeated in vitro stimulation with autologous tumor.
Journal of biological response modifiers 1990;9(4):431-8.
1990: Suzanne Topalian; A Kasid; STEVEN ROSENBERG
Immunoselection of a human melanoma resistant to specific lysis by autologous tumor-infiltrating lymphocytes. Possible mechanisms for immunotherapeutic failures.
Journal of immunology (Baltimore, Md. : 1950) 1990;144(11):4487-95.
1990: Suzanne Topalian; STEVEN ROSENBERG
Cellular immunotherapy of cancer.
Critical care medicine 1990;18(2 Suppl):S144.
1990: Suzanne Topalian; STEVEN ROSENBERG
Tumor-infiltrating lymphocytes: evidence for specific immune reactions against growing cancers in mice and humans.
Important advances in oncology 1990;():19-41.
1989: A Belldegrun; A Kasid; M Uppenkamp; Suzanne Topalian; STEVEN ROSENBERG
Human tumor infiltrating lymphocytes. Analysis of lymphokine mRNA expression and relevance to cancer immunotherapy.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(12):4520-6.
1989: Suzanne Topalian; D Solomon; STEVEN ROSENBERG
Tumor-specific cytolysis by lymphocytes infiltrating human melanomas.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(10):3714-25.
1989: H Stötter; E A Wiebke; S Tomita; A Belldegrun; Suzanne Topalian; STEVEN ROSENBERG; M T Lotze
Cytokines alter target cell susceptibility to lysis. II. Evaluation of tumor infiltrating lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(5):1767-73.
1989: Bernard Fisher; B S Packard; Elizabeth J Read; Jorge Carrasquillo; Charles S Carter; Suzanne Topalian; J C Yang; P Yolles; Steven M Larson; STEVEN ROSENBERG
Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(2):250-61.
1988: STEVEN ROSENBERG; B S Packard; P M Aebersold; D Solomon; Suzanne Topalian; S T Toy; P Simon; M T Lotze; J C Yang; Claudia A Seipp
Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report.
The New England journal of medicine 1988;319(25):1676-80.
1988: Suzanne Topalian; D Solomon; F P Avis; Alfred E Chang; D L Freerksen; W Marston Linehan; M T Lotze; C N Robertson; Claudia A Seipp; P Simon
Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(5):839-53.
1987: Suzanne Topalian; L M Muul; D Solomon; STEVEN ROSENBERG
Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials.
Journal of immunological methods 1987;102(1):127-41.
1987: Suzanne Topalian; M M Ziegler
Selection of optimal therapy for neuroblastoma: a study of the immunomodulatory effects of surgery and irradiation in the murine C1300 neuroblastoma model.
Journal of surgical oncology 1987;34(2):120-7.
1987: Suzanne Topalian; STEVEN ROSENBERG
Therapy of cancer using the adoptive transfer of activated killer cells and interleukin-2.
Acta haematologica 1987;78 Suppl 1():75-6.
1984: Suzanne Topalian; M M Ziegler
Necrotizing enterocolitis: a review of animal models.
The Journal of surgical research 1984;37(4):320-36.